Simple jQuery Dropdowns
Please use this identifier to cite or link to this item:
Title: Pro-invasive effect of proto-oncogene PBF is modulated by an interaction with cortactin
Authors: Rachel J. Watkins
Waraporn Imruetaicharoenchoke
Martin L. Read
Neil Sharma
Vikki L. Poole
Erica Gentilin
Sukhchain Bansal
Emy Bosseboeuf
Rachel Fletcher
Hannah R. Nieto
Ujjal Mallick
Allan Hackshaw
Hisham Mehanna
Kristien Boelaert
Vicki E. Smith
Christopher J. McCabe
University of Birmingham
Mahidol University
University of Ferrara
Universite de Poitiers
Freeman Hospital
Keywords: Biochemistry, Genetics and Molecular Biology;Medicine
Issue Date: 1-Dec-2016
Citation: Journal of Clinical Endocrinology and Metabolism. Vol.101, No.12 (2016), 4551-4563
Abstract: © 2016 by the Endocrine Society. Context: Metastatic disease is responsible for the majority of endocrine cancer deaths. New therapeutic targets are urgently needed to improve patient survival rates. Objective: The proto-oncogene PTTG1-binding factor (PBF/PTTG1IP) is overexpressed in multiple endocrine cancers and circumstantially associated with tumor aggressiveness. This study aimed to understand the role of PBF in tumor cell invasion and identify possible routes to inhibit its action. Design, Setting, Patients, and Interventions: Thyroid, breast, and colorectal cells were transfected with PBF and cultured for in vitro analysis. PBF and cortactin (CTTN) expression was determined in differentiated thyroid cancer and The Cancer Genome Atlas RNA-seq data. Primary Outcome Measure: Pro-invasive effects of PBF were evaluated by 2D Boyden chamber, 3D organotypic, and proximity ligation assays. Results: Our study identified that PBF and CTTN physically interact and co-localize, and that this occurs at the cell periphery, particularly at the leading edge of migrating cancer cells. Critically, PBF induces potent cellular invasion and migration in thyroid and breast cancer cells, which is entirely abrogated in the absence of CTTN. Importantly, we found that CTTN is over-expressed in differentiated thyroid cancer, particularly in patients with regional lymph node metastasis, which significantly correlates with elevated PBF expression. Mutation of PBF (Y174A) or pharmacological intervention modulates the PBF: CTTN interaction and attenuates the invasive properties of cancer cells. Conclusion: Our results demonstrate a unique role for PBF in regulating CTTN function to promote endocrine cell invasion and migration, as well as identify a new targetable interaction to block tumor cell movement.
ISSN: 19457197
Appears in Collections:Scopus 2016-2017

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.